Issue 42, 2014

Programmable drug release using bioresponsive mesoporous silica nanoparticles for site-specific oral drug delivery

Abstract

Novel mesoporous silica nanoparticles (MSNs) responsive to multiple biological stimuli (pH and enzymes) were prepared through conjugation with a structure modified soy protein isolate. The particles show an extremely high pro-drug (sulfasalazine) loading with programmable drug release in simulated gastrointestinal fluid.

Graphical abstract: Programmable drug release using bioresponsive mesoporous silica nanoparticles for site-specific oral drug delivery

Supplementary files

Article information

Article type
Communication
Submitted
24 Jan 2014
Accepted
17 Feb 2014
First published
17 Feb 2014

Chem. Commun., 2014,50, 5547-5550

Author version available

Programmable drug release using bioresponsive mesoporous silica nanoparticles for site-specific oral drug delivery

A. Popat, S. Jambhrunkar, J. Zhang, J. Yang, H. Zhang, A. Meka and C. Yu, Chem. Commun., 2014, 50, 5547 DOI: 10.1039/C4CC00620H

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements